Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-02-19

Clinical Trial Update: A Study of Cisplatin or Carboplatin With Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Patients With Resected or Ablation Intra-Hepatic Cholangiocarcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating cisplatin or carboplatin with gemcitabine versus gemcitabine alone as adjuvant therapy in intrahepatic cholangiocarcinoma has been wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARBOPLATIN (Carboplatin)
  • CISPLATIN (cisplatin)
  • Gemcitabine (Gemcitabine)

Snippet

Sponsor: University of Louisville | Conditions: Intrahepatic Cholangiocarcinoma | Phase 3 | Status: WITHDRAWN